Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-200
Closed 793
2022
Q2
$0 Buy
+200
New +$297 ﹤0.01% 1038
2017
Q3
Sell
-24,207
Closed -$584K 315
2017
Q2
$584K Hold
24,207
0.1% 177
2017
Q1
$480K Buy
+24,207
New +$540K 0.09% 172
2016
Q1
Sell
-17,054
Closed -$510K 239
2015
Q4
$510K Buy
17,054
+938
+6% +$31.6K 0.11% 134
2015
Q3
$508K Buy
+16,116
New +$786K 0.14% 119
2015
Q2
Sell
-18,434
Closed -$799K 215
2015
Q1
$799K Buy
+18,434
New +$662K 0.21% 103

Other funds holding PGEN

ACG Wealth's PGEN Position: Q3 2022 in Review

ACG Wealth sold out of Precigen (PGEN) in Q3 2022, closing a stake of 200 shares.

ACG Wealth first reported a position in PGEN in Q1 2015 and held it in 6 quarters. The position peaked at $799K in Q1 2015. 165 funds tracked by Wall St. Rank hold PGEN as of Q3 2022.

  • ACG Wealth reported no remaining Precigen position as of Q3 2022 after selling out during the quarter.
  • ACG Wealth sold 200 Precigen shares in Q3 2022.
  • ACG Wealth first reported a position in Precigen in Q1 2015 and held it in 6 quarters.
  • ACG Wealth's Precigen position peaked at $799K in Q1 2015.
  • 165 funds tracked by Wall St. Rank held Precigen as of Q3 2022.

Based on ACG Wealth's 13F filing for Q3 2022, filed 3 Nov 2022.